Exercise News and Research

Latest Exercise News and Research

CEO of pSivida to discuss new technologies in retinal drug delivery at the San Diego Ophthalmic summit

pSivida Corp, (NASDAQ:PSDV)(ASX:PSD)(FF:PSI), a leading drug delivery company, today announced that Dr. Paul Ashton, CEO, will lead a discussion on New Technologies in Retinal Drug Delivery at the 5th Annual Ophthalmic Drug Development and Delivery Summit to be held September 21-22, 2009 in San Diego.

19 Sep 2009

Maturity dates of Sonomax holders' notes extended

Sonomax Hearing Healthcare Inc. is very pleased to announce that the holders of 17 of the Company's 19 outstanding convertible promissory notes have agreed in writing to extend, in effect, the maturity date of their notes, which came due in April 2009.

19 Sep 2009

Spectrum Pharmaceuticals to raise funds from institutional investors for general corporate purposes

Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI), a commercial-stage biotechnology company with a focus in oncology, today announced that it has received commitments from institutional investors to purchase $50 million of securities in a registered direct offering.

19 Sep 2009

Newcardio raises funds through private placement

NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic technology provider, today announced that it closed a private placement financing with institutional and other accredited investors, including members of NewCardio's management team and board of directors, who purchased over half of the offering.

19 Sep 2009

Rodman & Renshaw acted as exclusive placement agent for Spectrum’s transaction

Rodman & Renshaw Capital Group, Inc., today announced that its client Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a focus in oncology, has received commitments from institutional investors to purchase $50 million of securities in a registered direct offering.

19 Sep 2009

Aptilon acquires Direct Medical Data and BLM Incorporated

Aptilon Corporation ("Aptilon" or the "Corporation") (TSX-V: APZ), a leading provider of physician access through its innovative alternative sales and marketing channel, today announced that it has acquired from Direct Medical Data, LLC ("DMD"), of Illinois, and BLM Incorporated ("BLM"), of Illinois, substantially all DMD and BLM assets related to their healthcare marketing services (the "Purchased Assets").

19 Sep 2009

Precise Biometrics successfully completes rights issue with preferential rights

Precise Biometrics AB has successfully completed a rights issue with preferential rights, which has supplied the Company with SEK 54.0 million prior to issue costs. The rights issue was subscribed to 178% and is implemented to finance further expansion and increase market penetration in prioritized segments.

18 Sep 2009

SXC Health Solutions to raise $176.6 million from sale of common shares

SXC Health Solutions Corp. ("SXC" or the "Company") (NASDAQ: SXCI, TSX: SXC) announced today the pricing of its previously announced public offering of common shares. Under the offering, SXC will sell 4,500,000 common shares at a price to the public of $41.50 per share.

18 Sep 2009

Metabolic Research to participate in the Olympia Expo

Metabolic Research, Inc., makers of Stemulite, will have a booth in the Olympia Expo at the Las Vegas Convention Center South Hall, September 25th and 26th. The Stemulite booth will feature Corey and Paul Simpson, well-known super athlete trainers joined by Cristi Cuellar, Miss Bikini Mexico International Elite Champion.

18 Sep 2009

White House says Baucus' 'building block' is not the end of the debate

President Barack Obama's spokesman, Robert Gibbs, called the health care reform plan released Wednesday by Senate Finance Committee Chairman Max Baucus "an important building block" that "gets us closer to comprehensive health care reform" Roll Call reports.

18 Sep 2009

Results from the BLOSSOM trial announced by Arena Pharmaceuticals

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) reported today positive, highly significant top-line results from the BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) trial.

18 Sep 2009

Diabetic nerve pain: Most bothersome complication of diabetes

In a new online survey, eighty-five percent of people who experience diabetic nerve pain said that their pain was one of the top three most bothersome complications of their diabetes. Despite the fact that people with diabetic nerve pain recognize the condition's impact on their lives and eighty-four percent of those surveyed said they have discussed the condition with a healthcare provider, just slightly less than half of respondents (49 percent) were treating their pain.

18 Sep 2009

Hythiam to raise $7 million by selling its common stock to institutional investors

Hythiam, Inc. (NASDAQ:HYTM) announced today that it has entered into definitive agreements to sell 9,333,334 shares of its common stock at a price per share of $.75 to institutional investors pursuant to a registered direct offering, representing gross proceeds of approximately $7 million.

18 Sep 2009

80-unit patient housing facility for cancer patients and families

The SCCA House, an 80-unit patient housing facility for cancer patients and their families and caregivers, was dedicated today during ceremonies at its South Lake Union location. The facility is the second such "home away from home" building that is operated by the Seattle Cancer Care Alliance. Rooms are scheduled to be available to SCCA patients by the end of the month.

18 Sep 2009

Parents' insurance status affects their children's health care--even when the children are insured

Insured children are less likely to have necessary health-care services if their parents are uninsured, according to a study published in the September/October issue of Annals of Family Medicine.

18 Sep 2009

African Americans at higher risk of developing potentially deadly DVT and PE than other ethnic populations

Speaking at the Venous Disease Coalition (VDC) Annual Meeting today, Dr. Garth Graham from the Office of Minority Health at the Department of Health and Human Services followed up on last year's Surgeon General's Call to Action by focusing attention on the African American population which is at significantly increased risk of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE).

18 Sep 2009

Educational initiative proves successful in identifying and diagnosing fibromyalgia

According to The Johns Hopkins University School of Medicine, the Fibromyalgia Circle of Care Initiative has achieved dramatic success in heightening awareness, diagnosis and best practice treatment of fibromyalgia – a complex and chronic pain disorder that plagues an estimated 10 million Americans.

17 Sep 2009

American Lung Association applauds EPA’s decision to reduce threat from dangerous air pollutant

Today the Administrator of the U.S. Environmental Protection Agency, Lisa Jackson, announced that the Agency will embark on a formal review of the national air quality standard for ozone, a decision that offers the opportunity to finally protect the health of millions of Americans from the most widespread and one of the most dangerous air pollutants.

17 Sep 2009

Helicos Biosciences to raise $10 million through private placement

Helicos BioSciences Corporation (NASDAQ: HLCS), a life science company focused on innovative genetic analysis technologies for the research, drug discovery, and diagnostic markets, today announced that it has entered into a definitive agreement with certain new and existing investors, including Atlas Ventures, Flagship Ventures, Highland Capital Partners, Versant Ventures (the “Existing Investors”) and Ron Lowy, the Company’s chief executive officer, to raise approximately $10 million in gross proceeds in a private placement through the sale of shares of its common stock and warrants.

17 Sep 2009

Mayo Clinic Women's HealthSource discusses myths and facts about ovarian cancer

But not all the news about ovarian cancer is grim. Incidence is declining. Doctors are learning more about early symptoms and more effective treatments. The September issue of Mayo Clinic Women's HealthSource looks at myths and facts about ovarian cancer.

17 Sep 2009